Picard Medical is trading 12.17% higher at $12.72 on October 13, with no clear catalyst identified for the gain. - The stock has climbed sharply in recent sessions. - October 13 reports highlighted a securities-lawsuit development and shareholder-law-firm investigations; available coverage does not establish either as the cause. - The broader market was nearly flat and healthcare was lower, offering no clear same-direction explanation.